New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
Columbia University College of Physicians and Surgeons, NYC, NY, USA.
J Clin Densitom. 2019 Jan-Mar;22(1):1-19. doi: 10.1016/j.jocd.2018.09.010. Epub 2018 Sep 22.
The Santa Fe Bone Symposium is an annual meeting devoted to clinical applications of recent advances in skeletal research. The 19th Santa Fe Bone Symposium convened August 3-4, 2018, in Santa Fe, New Mexico, USA. Attendees included physicians of many specialties, fellows in training, advanced practice providers, clinical researchers, and bone density technologists. The format consisted of lectures, case presentations by endocrinology fellows, and panel discussions, with all involving extensive interactive discussions. Topics were diverse, including an evolutionary history of calcium homeostasis, osteoporosis treatment in the very old, optimizing outcomes with orthopedic surgery, microbiome and bone, new strategies for combination and sequential therapy of osteoporosis, exercise as medicine, manifestations of parathyroid hormone excess and deficiency, parathyroid hormone as a therapeutic agent, cell senescence and bone health, and managing patients outside clinical practice guidelines. The National Bone Health Alliance conducted a premeeting on development of fracture liaison services. A workshop was devoted to Bone Health TeleECHO (Bone Health Extension for Community Healthcare Outcomes), a strategy of ongoing medical education for healthcare professions to expand capacity to deliver best practice skeletal healthcare in underserved communities and reduce the osteoporosis treatment gap.
圣达菲骨骼研讨会是一个年度会议，致力于骨骼研究最新进展的临床应用。第 19 届圣达菲骨骼研讨会于 2018 年 8 月 3 日至 4 日在美国新墨西哥州圣达菲举行。与会者包括许多专业的医生、培训中的研究员、高级执业医师、临床研究人员和骨密度技术人员。会议形式包括讲座、内分泌学研究员的病例介绍和小组讨论，所有这些都涉及广泛的互动讨论。主题多种多样，包括钙稳态的进化史、非常老的骨质疏松症治疗、骨科手术的优化结果、微生物组与骨骼、骨质疏松症联合和序贯治疗的新策略、运动作为医学、甲状旁腺激素过多和缺乏的表现、甲状旁腺激素作为治疗剂、细胞衰老与骨骼健康以及在临床实践指南之外管理患者。国家骨骼健康联盟在会前举行了关于骨折联络服务发展的会议。一个研讨会专门讨论了骨骼健康远程医疗 ECHO（骨骼健康延伸社区医疗保健成果），这是一种针对医疗保健专业人员的持续医学教育策略，旨在扩大在服务不足社区提供最佳实践骨骼保健的能力，并缩小骨质疏松症治疗差距。
